A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)

NCT04449029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: GSK3228836
DRUG: Placebo
DRUG: Nucleos(t)ide therapy

Sponsor

GlaxoSmithKline